Savara Inc
NASDAQ:SVRA
Savara Inc
Other Non-Cash Items
Savara Inc
Other Non-Cash Items Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Non-Cash Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Savara Inc
NASDAQ:SVRA
|
Other Non-Cash Items
$3m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
7%
|
|
|
Abbvie Inc
NYSE:ABBV
|
Other Non-Cash Items
$10.4B
|
CAGR 3-Years
28%
|
CAGR 5-Years
17%
|
CAGR 10-Years
19%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Other Non-Cash Items
$10.3B
|
CAGR 3-Years
55%
|
CAGR 5-Years
14%
|
CAGR 10-Years
36%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Other Non-Cash Items
$671m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
41%
|
CAGR 10-Years
9%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Other Non-Cash Items
$699.4m
|
CAGR 3-Years
17%
|
CAGR 5-Years
31%
|
CAGR 10-Years
15%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Other Non-Cash Items
$900.6m
|
CAGR 3-Years
5%
|
CAGR 5-Years
16%
|
CAGR 10-Years
8%
|
|
Savara Inc
Glance View
Savara, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. The company is headquartered in Austin, Texas and currently employs 22 full-time employees. The company went IPO on 2001-06-25. The firm is focused on rare respiratory diseases. The Company’s lead program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase III development for autoimmune pulmonary alveolar proteinosis (aPAP). Molgramostim an inhaled formulation of recombinant human GM-CSF, is being developed for the treatment of aPAP. Pulmonary alveolar proteinosis (PAP) is a rare lung disease characterized by the build-up of surfactant in the alveoli or air sacs of the lungs.
See Also
What is Savara Inc's Other Non-Cash Items?
Other Non-Cash Items
3m
USD
Based on the financial report for Sep 30, 2024, Savara Inc's Other Non-Cash Items amounts to 3m USD.
What is Savara Inc's Other Non-Cash Items growth rate?
Other Non-Cash Items CAGR 10Y
7%
Over the last year, the Other Non-Cash Items growth was 14 795%. The average annual Other Non-Cash Items growth rates for Savara Inc have been -17% over the past three years , -24% over the past five years , and 7% over the past ten years .
You don't have any saved screeners yet